Cure My Disease

Don't miss your cure!

 Log in / Sign up

Lung transplant Patients' arm strength lags behind healthy peers

NCT ID NCT07065981

Knowledge-focused Sponsor: Ankara City Hospital Bilkent Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at arm exercise ability in 60 people—some who had a lung transplant and some healthy volunteers. Researchers used a simple pegboard test to measure arm endurance. The goal was to see if transplant recipients have weaker arm function and how that relates to their breathing, fatigue, and quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

60 people

The number who actually took part.

Started

Jun 2025

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Lung transplant patients who are being followed up at Bilkent City Hospital Chest Surgery Clinic

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Inclusion Criteria for Lung Transplant Recipients: * Patients aged 18-70 years * At least 3 months post-lung transplantation with no major complications * Clinically stable with any comorbidities under control * Willing to participate in the study * No neurological or orthopedic conditions that may interfere with functional testing * Sufficient cognitive level to understand and perform required tests and questionnaires Inclusion Criteria for Healthy Controls: * Aged 18-70 years * Sufficient cognitive ability to understand and complete the tests * Willing to participate in the study Exclusion Criteria: Exclusion Criteria for Lung Transplant Recipients: * Single-lung transplant recipients * Patients with orthopedic limitations * Patients unable to cooperate or comply with study procedures * Patients with mental disorders Exclusion Criteria for Healthy Controls: * Presence of cardiovascular diseases, cerebrovascular disease, dementia, chronic pulmonary diseases, moderate-to-severe liver diseases, hemiplegia, moderate or severe kidney disease, or solid tumors * Orthopedic conditions that would prevent exercise testing Inability to cooperate or comply with study procedures

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Transplant recipient are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Transplant recipient

Contacts and locations

Locations

  • Bilkent City Hospital

    Ankara, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.